Statistics for A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma.
Total visits
| views | |
|---|---|
| A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glioblastoma. | 28 |
Total visits per month
| views | |
|---|---|
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 1 |
| October 2024 | 0 |
File Visits
| views | |
|---|---|
| A novel recombinant immunotoxin-based therapy targeting wild-type and mutant EGFR improves survival in murine models of glio.pdf | 16 |